Fineotex Chemical Fund Utilization Confirmed by ICRA

Fineotex Chemical Ltd. has received confirmation from ICRA, its appointed Monitoring Agency, that the net proceeds from its preferential issue have been fully utilized. The report confirms the INR 91.963 crore in net proceeds have been deployed for the company's stated expansion objectives and working capital needs, covering the period through March 31, 2026.

Issue Revision and Fund Deployment

This confirmation follows a significant revision in the issue size. Fineotex Chemical had initially aimed to raise INR 280.350 crore through a preferential issue announced on May 22, 2024. However, the issue faced undersubscription, leading to a reduced total amount raised. Associated costs for the project objectives were adjusted downwards, remaining within a +/-10% range of the revised INR 91.963 crore.

Stakeholder Assurance and Compliance

The ICRA report provides assurance to stakeholders that the funds secured, though less than initially planned, are being applied as intended for business expansion. This addresses potential concerns arising from the undersubscription of the larger initial issue. Compliance with regulatory requirements for preferential issues is maintained, and the scale of expansion projects is aligned with the revised INR 91.963 crore proceeds. The company is working towards completing its project objectives by the September 30, 2030 deadline.

Potential Concerns and Market Signals

However, the substantial undersubscription of the original INR 280.350 crore issue could signal challenges in market appetite for such large fundraising efforts. It is also noted that the Monitoring Agency report does not comment on the appropriateness or reasonableness of costs, nor does it provide assurance on the outcome of the spending.

Industry Context and Financial Health

In terms of industry context, peer companies like Aarti Industries and Aether Industries also undertake significant capital expenditure, often funding growth through a mix of internal accruals, debt, or institutional placements such as QIPs. As of FY23, Fineotex Chemical reported contingent liabilities of INR 106.0 crore and maintained a low Debt to Equity Ratio of 0.08, indicating a strong reliance on equity financing and minimal leverage.

Looking Ahead

Investors will be monitoring the progress of the project objectives towards the September 30, 2030 deadline. Future announcements regarding the performance of expanded capacities, any subsequent fundraising plans, and management commentary on the factors leading to the preferential issue's undersubscription will be key areas of focus.